Dear Editor, The growing understanding of communication between the nervous and immune systems has shifted biomedical research toward a more integrated systems-based approach. The neuroimmune connectome describes the dynamic interaction between neural and immune cells and provides a framework for understanding how these systems cooperate in health and disease. Beyond a theoretical concept, current advances in molecular biology and computational science now allow these interactions to be quantified and translated into clinically meaningful observations. Recent progress in single-cell sequencing and spatial transcriptomics has significantly improved our understanding of neuroimmune signaling. Studies of human brain tissue have identified multiple microglial states linked to inflammation, tissue repair, and synaptic regulation. Disease-associated microglia demonstrate increased expression of inflammatory and phagocytic genes, suggesting that immune activity in the central nervous system exists along a dynamic spectrum rather than as a simple on–off process.1 These findings support the idea that immune responses actively contribute to neuronal function and dysfunction. Neurodegenerative diseases provide strong evidence for the clinical relevance of neuroimmune mechanisms. In Alzheimer’s disease, increased inflammatory signaling and immune-cell activation are consistently observed in both brain tissue and cerebrospinal fluid.2-4 Experimental studies further indicate that modulation of inflammatory pathways may reduce neuronal injury and delay disease progression.3 Such findings highlight the potential of neuroimmune pathways as therapeutic targets in neurodegenerative disorders. Neuroimmune signaling also influences behavior and psychiatric health. Human studies have demonstrated that inflammatory cytokines can alter functional brain connectivity and contribute to symptoms such as fatigue, low motivation, and social withdrawal.5 Importantly, several of these changes appear reversible, suggesting that targeted immune modulation may offer therapeutic benefit in selected neuropsychiatric conditions. Environmental factors contribute substantially to neuroimmune regulation. Gut microbiota-derived metabolites influence systemic inflammation and immune-cell behavior, thereby affecting neural signaling and behavior.6 Experimental manipulation of the gut microbiome has been associated with changes in immune-cell populations and anxiety-related behaviors in animal models. These observations reinforce the importance of the gut–brain–immune axis as a modifiable component of the neuroimmune connectome. Bioinformatics and systems biology approaches have become essential for interpreting the complexity of neuroimmune interactions. Network-based computational analyses can identify key regulatory hubs involved in cell signaling and inflammatory pathways.7 Machine-learning methods applied to multi-omics datasets have also shown promising ability in differentiating disease states from healthy conditions. These computational strategies may help improve biomarker discovery, patient stratification, and personalized therapeutic approaches Figure 1.Figure 1: Simplified overview of the neuroimmune connectome showing interactions between the brain, immune system, gut microbiota, and computational analysis platformsDespite these advances, several challenges remain. Integration of molecular, spatial, and temporal data is still difficult because of variability in experimental methods and limited standardization across studies. In addition, many findings remain associative rather than causal. Future studies should therefore emphasize longitudinal analysis, harmonized datasets, and translational validation to improve reproducibility and clinical applicability. In conclusion, the neuroimmune connectome is evolving from a conceptual framework into a measurable and clinically relevant field supported by experimental biology and computational science. Improved understanding of neuroimmune communication may facilitate early diagnosis, biomarker identification, and development of targeted therapies for neurological and neuropsychiatric disorders. Continued integration of systems biology, bioinformatics, and clinical research will be essential for translating these discoveries into practical patient care. Author contribution The author confirms that all scientific concepts, literature review, data interpretation, and manuscript preparation were independently performed by the author. The manuscript content reflects the author’s original intellectual contribution. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Roopesh Jain (Wed,) studied this question.